Attenuation of alpha-adrenergic responsiveness in hypoxic SHR

Clinical and Experimental Hypertension. Part A, Theory and Practice
W N Henley, A Tucker

Abstract

Chronic exposure to hypoxia reduces the severity of hypertension in SHR. This study explored the possibility that hypoxic moderation of spontaneous hypertension is caused by a decrease in vascular responsiveness. In vitro studies were conducted with thoracic aortic rings obtained from SHR and Wistar-Kyoto (WKY) rats maintained under hypoxic (H; simulated altitude = 3658 m) and normoxic (N; laboratory altitude = 1520 m) conditions. Vessels were removed prior to the rapid development of hypertension (5 weeks of age; 3 days of altitude exposure), during the rapid hypertension-development stage (10 weeks of age; 5 weeks of altitude exposure), and during the established hypertension stage (18 to 20 weeks of age; 11 to 13 weeks of altitude exposure). Dose-response curves were obtained using a non-specific vasoconstrictor (KCl) and an alpha-adrenergic agonist, phenylephrine. At all ages, WKY vessels developed greater maximal contraction to vasoconstrictor stimuli, whereas vessels from the two older groups of SHR were more sensitive (more responsive at lower dosages) to KCl. Hypoxia caused significant (p less than 0.05) attenuation of the contractile responses to phenylephrine in young "pre-hypertensive" SHR, while similar, though less...Continue Reading

References

May 1, 1975·Circulation Research·T R Hansen, D F Bohr
Jun 1, 1975·Circulation Research·L T Lais, M J Brody
Dec 1, 1973·Circulation Research·E T Holloway, D F Bohr
Aug 1, 1971·Canadian Journal of Physiology and Pharmacology·W S Myles, A J Ducker
May 1, 1970·Proceedings of the Society for Experimental Biology and Medicine·M J Fregly
Sep 1, 1969·The American Journal of Physiology·V S Aoki, S M Robinson
Jul 1, 1984·Hypertension·J H LombardW J Stekiel
Jan 1, 1982·Biulleten' eksperimental'noĭ biologii i meditsiny·N A BarbarashT G Putintseva
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·G M Walsh, A J Tobia
Jan 1, 1980·Canadian Journal of Physiology and Pharmacology·V C Swamy, D J Triggle

Citations

Jun 1, 1989·Brain Research Bulletin·W N Henley, L L Bellush
Apr 15, 2008·Experimental Biology and Medicine·Tatiana V SerebrovskayaRobert T Mallet

Related Concepts

Metazoa
Anoxemia
Descending Aorta
Diastolic Blood Pressure
Dose-Response Relationship, Drug
Hypertensive Disease
Mezaton
Slow-K
Randomization
Rats, Inbred SHR

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.